Women Can Take Antidepressants During Pregnancy

Women Can Take Antidepressants During Pregnancy.
Women who study infallible antidepressants while abounding do not raise the risk of a stillbirth or demise of their baby in the first year of life, according to a bountiful new study. The findings stanch from an analysis involving 30000 women in Denmark, Finland, Iceland, Norway and Sweden, who gave beginning to more than 1,6 million babies, in total, between 1996 and 2007 malesize. Close to 2 percent of the women took medication demanding serotonin reuptake inhibitors (SSRIs), such as Prozac (fluoxetine) and Paxil (paroxetine), for depressive symptoms during their pregnancy.

The scrutinization team, led by Dr Olof Stephansson of the Karolinska Institute in Stockholm, Sweden, reports in the Jan 2, 2013 issuing of the Journal of the American Medical Association that initially women taking an SSRI for the dumps did seem to happening statistically higher rates of stillbirth and infant death worldedhelp. However, that uptick in imperil disappeared once they accounted for other factors, including the foreboding posed by unhappiness and the mother's information of psychiatric sickness or hospitalizations, the authors illustrious in a record info release.

And "The file meditate on of more than 1,6 million births suggests that SSRI use during pregnancy was not associated with increased risks of stillbirth, neonatal liquidation or postneonatal death," Stephansson's rig reported. "The increased rates of stillbirth and postneonatal mortality mid infants exposed to an SSRI during pregnancy were explained by the dangerousness of the underlying motherly psychiatric bug and unfavorable parcelling of devoted characteristics such as cigarette smoking and advanced warm age," the authors added.

Depression during pregnancy affects between 7 percent and 19 percent of mothers-to-be in economically developed countries, the authors penetrating out in the report. "Maternal the blues is associated with poorer pregnancy outcomes, including increased danger of preterm delivery, which in rot may cause neonatal morbidity and mortality".

The tandem acknowledged that use of SSRIs during pregnancy has been associated with descent defects, neonatal withdrawal syndrome and pulmonary hypertension of the newborn, which is what led to the inclination study. Although they found that the drugs posed no spontaneous jeopardize pertaining to stillbirth or infant death, the authors urged mothers and physicians to style SSRI use carefully vito mol. "Decisions concerning use of SSRIs during pregnancy must knock off into account other perinatal outcomes and the risks associated with kindly unstable illness," Stephansson and colleagues concluded.